Easton Pharmaceutica Stock Today

EAPH Stock  USD 0.0001  0.00  0.00%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Over 86

 
High
 
Low
Very High
Easton Pharmaceutica is trading at 1.0E-4 as of the 31st of January 2025. This is a No Change since the beginning of the trading day. The stock's open price was 1.0E-4. Easton Pharmaceutica has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 3rd of September 2024 and ending today, the 31st of January 2025. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
22nd of July 1999
Category
Healthcare
Classification
Health Care
Parallel Industries Inc. does not have significant operations. Parallel Industries Inc. was founded in 1997 and is headquartered in Toronto, Canada. Easton Pharmaceuticals is traded on OTC Exchange in the United States. The company has 1.34 B outstanding shares. More on Easton Pharmaceutica

Easton Stock Highlights

Business ConcentrationPharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors)
Debt Levels
Easton Pharmaceutica can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Easton Pharmaceutica's financial leverage. It provides some insight into what part of Easton Pharmaceutica's total assets is financed by creditors.
Liquidity
Easton Pharmaceutica currently holds 3.28 M in liabilities with Debt to Equity (D/E) ratio of 0.43, which is about average as compared to similar companies. Easton Pharmaceutica has a current ratio of 0.68, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Easton Pharmaceutica's use of debt, we should always consider it together with its cash and equity.

Change To Liabilities

241,731
Easton Pharmaceutica (EAPH) is traded on OTCCE Exchange in USA and employs 4 people. Easton Pharmaceutica is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 134.49 K. Easton Pharmaceutica conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 1.34 B outstanding shares. Easton Pharmaceutica currently holds about 5.81 K in cash with (188.54 K) of positive cash flow from operations.
Check Easton Pharmaceutica Probability Of Bankruptcy

Easton Stock Against Markets

When determining whether Easton Pharmaceutica offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Easton Pharmaceutica's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Easton Pharmaceutica Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Easton Pharmaceutica Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Easton Pharmaceutica. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For more detail on how to invest in Easton Stock please use our How to Invest in Easton Pharmaceutica guide.
You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Easton Pharmaceutica. If investors know Easton will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Easton Pharmaceutica listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share
0.001
Return On Assets
(0.01)
Return On Equity
(0.03)
The market value of Easton Pharmaceutica is measured differently than its book value, which is the value of Easton that is recorded on the company's balance sheet. Investors also form their own opinion of Easton Pharmaceutica's value that differs from its market value or its book value, called intrinsic value, which is Easton Pharmaceutica's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Easton Pharmaceutica's market value can be influenced by many factors that don't directly affect Easton Pharmaceutica's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Easton Pharmaceutica's value and its price as these two are different measures arrived at by different means. Investors typically determine if Easton Pharmaceutica is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Easton Pharmaceutica's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.